ARCTURUS THERAPEUTICS HLDG I's ticker is and the CUSIP is 03969T959. A total of 4 filers reported holding ARCTURUS THERAPEUTICS HLDG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,500 | -47.6% | 30,000 | -41.2% | 0.00% | -40.0% |
| Q2 2023 | $1,462,680 | +22.5% | 51,000 | +2.4% | 0.01% | +25.0% |
| Q1 2023 | $1,193,706 | +151.4% | 49,800 | +77.9% | 0.00% | +300.0% |
| Q4 2022 | $474,880 | -50.2% | 28,000 | -56.5% | 0.00% | -50.0% |
| Q3 2022 | $954,000 | -14.4% | 64,400 | -9.0% | 0.00% | 0.0% |
| Q2 2022 | $1,114,000 | -28.8% | 70,800 | +22.1% | 0.00% | 0.0% |
| Q1 2022 | $1,564,000 | -40.6% | 58,000 | -18.4% | 0.00% | 0.0% |
| Q4 2021 | $2,631,000 | +12.1% | 71,100 | +44.8% | 0.00% | -33.3% |
| Q3 2021 | $2,346,000 | +336.1% | 49,100 | +208.8% | 0.00% | +200.0% |
| Q2 2021 | $538,000 | -80.0% | 15,900 | -75.6% | 0.00% | -75.0% |
| Q1 2021 | $2,693,000 | -4.6% | 65,200 | +0.2% | 0.00% | -20.0% |
| Q4 2020 | $2,824,000 | +28.6% | 65,100 | +27.1% | 0.01% | -28.6% |
| Q3 2020 | $2,196,000 | -27.3% | 51,200 | -20.7% | 0.01% | -50.0% |
| Q2 2020 | $3,019,000 | +563.5% | 64,600 | +92.8% | 0.01% | +250.0% |
| Q1 2020 | $455,000 | +22.3% | 33,500 | -2.0% | 0.00% | +33.3% |
| Q4 2019 | $372,000 | +61.7% | 34,200 | +52.7% | 0.00% | +50.0% |
| Q3 2019 | $230,000 | – | 22,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 106 | $460,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 65,100 | $2,824,000 | 0.01% |
| SIMPLEX TRADING, LLC | 582 | $2,524,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |